More layoffs hit Biogen as drugmaker cuts multiple sclerosis team
After cutting its headcount by nearly 1,000 workers last year, Biogen has continued to cut jobs in 2023.
After cutting its headcount by nearly 1,000 workers last year, Biogen has continued to cut jobs in 2023.